Harvard Bioscience(HBIO)
$9.39+0.18 (+1.90%)
HBIO
Harvard Bioscience Revenue
$9.39
At close:+0.18 (+1.90%)
Want to see HBIO full AI Analyst Report?
Harvard Bioscience (HBIO) Revenue
278 Followers
Harvard Bioscience Revenue
Harvard Bioscience had a revenue of 22.20M in the quarter ending Sep 30, 2026, with -2.34%. This bring the company's revenue in the last twelve months to 89.41M, Increased 1.83%. In the fiscal year ending Dec 31, 2025, Harvard Bioscience had annual revenue of 86.55M with -8.06% growth.
- Revenue (ttm)
- 89.41M
- Revenue Growth
- 2.34%
- P/S Ratio
- 0.50
- Revenue/Employee
- $263,872
- Employees
- 328
- Market Cap
- $42.94M
Revenue Chart
Harvard Bioscience Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 86.55M | -7.58M | -8.06% |
| Dec 31, 2024 | 94.14M | -18.11M | -16.14% |
| Dec 31, 2023 | 112.25M | -1.08M | -0.96% |
| Dec 31, 2022 | 113.33M | -5.57M | -4.68% |
| Dec 31, 2021 | 118.90M | 16.80M | 16.46% |
| Dec 31, 2020 | 102.10M | -14.08M | -12.12% |
| Dec 31, 2019 | 116.18M | -4.60M | -3.81% |
| Dec 31, 2018 | 120.77M | 18.89M | 18.54% |
| Dec 31, 2017 | 101.88M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

